A detailed history of Douglas Lane & Associates, LLC transactions in Danaher Corp stock. As of the latest transaction made, Douglas Lane & Associates, LLC holds 322,540 shares of DHR stock, worth $85.9 Million. This represents 1.17% of its overall portfolio holdings.

Number of Shares
322,540
Previous 322,889 0.11%
Holding current value
$85.9 Million
Previous $80.6 Million 0.06%
% of portfolio
1.17%
Previous 1.19%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 08, 2024

SELL
$235.51 - $267.98 $82,192 - $93,525
-349 Reduced 0.11%
322,540 $80.6 Million
Q1 2024

Apr 11, 2024

SELL
$224.58 - $256.19 $193,138 - $220,323
-860 Reduced 0.27%
322,889 $80.6 Million
Q4 2023

Jan 17, 2024

SELL
$185.1 - $233.13 $1.39 Million - $1.75 Million
-7,515 Reduced 2.27%
323,749 $74.9 Million
Q3 2023

Oct 16, 2023

SELL
$233.08 - $265.59 $326,312 - $371,825
-1,400 Reduced 0.42%
331,264 $82.2 Million
Q2 2023

Jul 19, 2023

SELL
$224.99 - $256.14 $1.32 Million - $1.51 Million
-5,889 Reduced 1.74%
332,664 $79.8 Million
Q1 2023

Apr 17, 2023

SELL
$239.75 - $277.0 $1.72 Million - $1.99 Million
-7,188 Reduced 2.08%
338,553 $85.3 Million
Q4 2022

Feb 14, 2023

SELL
$241.42 - $282.29 $342,333 - $400,287
-1,418 Reduced 0.41%
345,741 $91.8 Million
Q4 2022

Jan 17, 2023

SELL
$241.42 - $282.29 $8.24 Million - $9.63 Million
-34,122 Reduced 8.95%
347,159 $92.1 Million
Q3 2022

Oct 14, 2022

SELL
$247.06 - $1507.4 $3.36 Million - $20.5 Million
-13,608 Reduced 3.45%
381,281 $98.5 Million
Q2 2022

Jul 18, 2022

SELL
$237.11 - $299.66 $2.23 Million - $2.82 Million
-9,425 Reduced 2.33%
394,889 $100 Million
Q1 2022

Apr 25, 2022

SELL
$257.27 - $315.76 $6.23 Million - $7.65 Million
-24,234 Reduced 5.65%
404,314 $119 Million
Q4 2021

Jan 25, 2022

SELL
$292.08 - $329.01 $8.71 Million - $9.81 Million
-29,809 Reduced 6.5%
428,548 $141 Million
Q3 2021

Oct 21, 2021

SELL
$272.21 - $332.43 $5.08 Million - $6.2 Million
-18,664 Reduced 3.91%
458,357 $140 Million
Q2 2021

Jul 19, 2021

SELL
$225.08 - $271.69 $1.76 Million - $2.13 Million
-7,833 Reduced 1.62%
477,021 $128 Million
Q1 2021

Apr 19, 2021

SELL
$212.38 - $245.9 $2.31 Million - $2.67 Million
-10,875 Reduced 2.19%
484,854 $109 Million
Q4 2020

Jan 14, 2021

SELL
$212.5 - $245.46 $3.44 Million - $3.98 Million
-16,203 Reduced 3.17%
495,729 $110 Million
Q3 2020

Oct 19, 2020

SELL
$177.16 - $215.33 $3.58 Million - $4.35 Million
-20,192 Reduced 3.79%
511,932 $110 Million
Q2 2020

Jul 28, 2020

SELL
$128.7 - $176.83 $919,175 - $1.26 Million
-7,142 Reduced 1.32%
532,124 $94.1 Million
Q1 2020

Apr 20, 2020

SELL
$121.39 - $169.05 $2.12 Million - $2.96 Million
-17,481 Reduced 3.14%
539,266 $74.6 Million
Q4 2019

Jan 27, 2020

SELL
$133.47 - $153.48 $734,885 - $845,060
-5,506 Reduced 0.98%
556,747 $85.5 Million
Q3 2019

Oct 16, 2019

SELL
$135.4 - $146.47 $1.15 Million - $1.24 Million
-8,467 Reduced 1.48%
562,253 $81.2 Million
Q2 2019

Jul 08, 2019

SELL
$124.88 - $143.73 $766,888 - $882,645
-6,141 Reduced 1.06%
570,720 $81.6 Million
Q1 2019

Apr 23, 2019

BUY
$97.62 - $132.29 $181,573 - $246,059
1,860 Added 0.32%
576,861 $76.2 Million
Q4 2018

Jan 17, 2019

BUY
$94.85 - $109.54 $1.91 Million - $2.21 Million
20,154 Added 3.63%
575,001 $59.3 Million
Q3 2018

Oct 09, 2018

BUY
$98.13 - $108.9 $1.57 Million - $1.74 Million
16,006 Added 2.97%
554,847 $60.3 Million
Q2 2018

Jul 23, 2018

SELL
$96.1 - $103.24 $342,980 - $368,463
-3,569 Reduced 0.66%
538,841 $53.2 Million
Q1 2018

Apr 23, 2018

SELL
$92.16 - $103.8 $390,481 - $439,800
-4,237 Reduced 0.78%
542,410 $53.1 Million
Q4 2017

Jan 24, 2018

BUY
$85.26 - $94.62 $370,028 - $410,650
4,340 Added 0.8%
546,647 $50.7 Million
Q3 2017

Oct 19, 2017

BUY
$79.29 - $88.45 $43 Million - $48 Million
542,307
542,307 $46.5 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $194B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Douglas Lane & Associates, LLC Portfolio

Follow Douglas Lane & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Douglas Lane & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Douglas Lane & Associates, LLC with notifications on news.